| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |